- The Myeloma Beacon - https://myelomabeacon.org -
Doxil (doxorubicin HCl liposome injection)
By: Admin; Published: October 15, 2008 @ 8:00 am | Comments Disabled
Brand Name: | Doxil | |
Generic Name: | doxorubicin HCl liposome injection | |
Code Name: | ||
Company: | Ortho Biotech | |
FDA Clinical Phase: | 1,2, & 3 |
Description:
Doxil is a form of the anticancer drug doxorubicin that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than doxorubicin. Doxil is used to treat ovarian cancer, AIDS [1]-related Kaposi sarcoma, and multiple myeloma in patients whose disease has not gotten better after treatment with other anticancer drugs. It may be used together with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Doxil is a type of anthracycline antitumor antibiotic.
Clinical Trials:
For a list of clinical trials studying Doxil for the treatment of multiple myeloma, see ClinicalTrials.gov [2].
Official website for Doxil: http://www.doxil.com/ [3]
Article printed from The Myeloma Beacon: https://myelomabeacon.org
URL to article: https://myelomabeacon.org/resources/2008/10/15/doxil/
URLs in this post:
[1] AIDS: http://www.aidsbeacon.com/
[2] ClinicalTrials.gov: http://www.clinicaltrial.gov/ct2/results?term=Doxil&recr=&rslt=&type=&cond=multiple+myeloma&intr=&outc=&lead=&spons=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&gndr=&rcv_s=&rcv_e=&lup_s=&lup_e=
[3] http://www.doxil.com/: http://www.doxil.com/
[4] http://www.cancer.gov/templates/db_alpha.aspx?searchTxt=doxil: http://www.cancer.gov/templates/db_alpha.aspx?searchTxt=doxil
Click here to print.
Copyright © The Beacon Foundation for Health. All rights reserved.